Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk

Kristine M. Erlandson, Kathleen V. Fitch, Sara A. McCallum, Heather J. Ribaudo, Edgar T. Overton, Markella V. Zanni, Gerald S. Bloomfield, Todd T. Brown, Carl J. Fichtenbaum, Sara Bares, Judith A. Aberg, Pamela S. Douglas, Evelynne S. Fulda, Jorge L. Santana-Bagur, Jose G. Castro, Laura E. Moran, Vidya Mave, Khuanchai Supparatpinyo, Ponego L. Ponatshego, Mauro SchechterSteven K. Grinspoon

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


BACKGROUND: We sought to explore multinational differences in functional status by global burden of disease (GBD) regions in the REPRIEVE cohort. METHODS: REPRIEVE is a prospective, double-blind, randomized, placebo-controlled, multicenter, phase III primary cardiovascular prevention study of pitavastatin calcium vs placebo among people with human immunodeficiency virus (HIV, PWH) ages 40-75 on antiretroviral therapy (ART). GBD super regions were defined using World Health Organization classifications. Participants were categorized by impairment on the Duke Activity Status Instrument (DASI: none, some, moderate, severe). Logistic regression models examined risk factors and GBD regions associated with functional impairment. The association between functional impairment and cardiometabolic risk was also explored. RESULTS: Of 7736 participants, the majority were from high-income countries (n = 4065), were male (65%), and had received ART for ≥ 10 years. The median DASI score was 58.2 (interquartile range [IQR] 50.2, 58.2); 36% reported at least some impairment. In adjusted analyses, functional impairment was significantly more frequent among participants from Southeast/East Asia. Other factors associated with greater impairment included female sex, Black race, older age, current/former smoking, higher body mass index, use of ART for ≥ 10 years, and select ART regimens; differences were seen in risks across GBD regions. Functional impairment was associated with increased cardiometabolic risk. CONCLUSIONS: Over 1/3 of middle-aged and older PWH in a global cohort across diverse GBD regions demonstrate functional impairments. The associations between DASI and cardiometabolic risk suggest that a measure of functional status may improve risk prediction; these longitudinal associations will be further investigated over REPRIEVE trial follow-up.

Original languageEnglish (US)
Pages (from-to)1154-1163
Number of pages10
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue number7
StatePublished - Sep 30 2022


  • aging
  • cardiovascular disease
  • frailty
  • functional status
  • physical function

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk'. Together they form a unique fingerprint.

Cite this